Evidence map›Paper›PMID 42179718›Full record

ArticleCase reports in oncological medicine2026

Scalp and Neck Metastasis From HER2-Positive Gastric Cancer: A Case Report and Literature Review.

Ricardo Fernández-Ferreira, Jesus Montaño-Hernández, Rafael-Garza Cantú-Pedraza, Fernanda Delgado-Gutierrez, Renato-Adrian Flores-Vazquez, Mauricio-Lohengrin Durán-Aceves, Verónica Bautista-Piña, Rosa-María Vicuña-González, María-Del-Carmen Burguete-Bojalil, Giovana-Ivette De-Lucio-Chavero

Abstract read
In one paragraph

Article in Case reports in oncological medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ricardo Fernández-FerreiraOncology Medical (Oncology Department), Pemex (Mexico), Mexico City, Mexico.ORCID https://orcid.org/0000-0002-6886-4345
Jesus Montaño-HernándezPathology Department, Pemex (Mexico), Mexico City, Mexico.ORCID https://orcid.org/0009-0009-1048-5682
Rafael-Garza Cantú-PedrazaOncology Department, National Autonomous University of Mexico, Mexico City, Mexico, unam.mx.
Fernanda Delgado-GutierrezOncology Medical (Oncology Department), Medica Sur, Mexico City, Mexico.
Renato-Adrian Flores-VazquezOncology Medical (Oncology Department), Pemex (Mexico), Mexico City, Mexico.
Mauricio-Lohengrin Durán-AcevesOncology Medical (Oncology Department), Pemex (Mexico), Mexico City, Mexico.
Verónica Bautista-PiñaPathology Department, Pemex (Mexico), Mexico City, Mexico.
Rosa-María Vicuña-GonzálezPathology Department, Pemex (Mexico), Mexico City, Mexico.
María-Del-Carmen Burguete-BojalilOncology Medical (Oncology Department), Medica Sur, Mexico City, Mexico.
Giovana-Ivette De-Lucio-ChaveroOncology Medical (Oncology Department), Medica Sur, Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cutaneous metastasis of gastric cancer is a rare manifestation (2.6%) of advanced gastrointestinal cancers and occurs in less than 1% of upper GI tract malignancies. The nodular type is the most common type. Tissue diagnosis and anatomic localization of the primary tumor are best obtained by upper gastrointestinal endoscopy. However, when the patient presents with dermatological and scalp lesions, the procedure is to take a targeted biopsy of said lesions. Case Summary: A 60-year-old female with advanced disease (Stage IV HER2-positive gastric cancer) was diagnosed due to skin metastases: erythematous alopecic skin lesions on the central scalp, as well as a raised, erythematous, indurated, nontender, irregular 6 × 8 cm lesion on the cervicodorsal region. Treatment with capecitabine + oxaliplatin + trastuzumab every 3 weeks was initiated. By the sixth cycle, the scalp lesion had resolved completely, and the cervical lesion had reduced to 3 × 4 cm. After 1 year of treatment, the lesions continued to show a favorable response. Conclusions: To the best of our knowledge, this is the second reported case of cutaneous metastases from HER2-positive gastric cancer. Fewer than 20 cases involving metastases to the scalp and neck region have been reported in the English-language literature.

Indexed as

gastric cancerHER2-positivescalpskin metastasistrastuzumab

Identifiers

PMID42179718
PMCPMC13197652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.